发明名称 |
Controlled Release Systems of Pluribioactive Antifungal Drugs |
摘要 |
Controlled release systems release at least one pluribioactive antifungal drug exhibiting at least one additional bioactivity from the group consisting of spermiostatic, antineoplastic, antibacterial, antirestenotic and antiviral activities. The drug release system is designed for use as a spermiostatic contraceptive, intravaginal ringed-mesh which may also exhibit antiviral activity, an in situ-forming implant for treating different forms of cancer and topical film for treating or preventing bacterial and fungal infections. |
申请公布号 |
US2015283160(A1) |
申请公布日期 |
2015.10.08 |
申请号 |
US201514685085 |
申请日期 |
2015.04.13 |
申请人 |
Poly-Med, Inc. |
发明人 |
Shalaby Shalaby W.;Hilas Georgios T.;Nagatomi Shelia |
分类号 |
A61K31/7048;A61K31/496;A61K31/506;A61K31/4174 |
主分类号 |
A61K31/7048 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating cancer comprising employing an antifungal drug selected from the group consisting of miconazole, ketoconazole, itraconazole, voriconazole, and amphotericin B, the antifungal drug exhibiting antineoplastic activity, wherein the antifungal drug is introduced into the body by means of a drug release system comprising an polymeric implant having the antifungal drug incorporated therein. |
地址 |
Anderson SC US |